Molplex
Newcastle Upon Tyne
About Molplex
Molplex is a uniquely scalable and low risk drug discovery solutions business exploiting novel software systems for automating drug design, on demand laboratory operations and a flexible network of experienced drug discovery scientists. Molplex offers drug discovery teams based anywhere in the world online drug design, including multi-property optimisation, assay ready chemical supply, SPR-based high content biological screening and other lead discovery and lead optimisation solutions. Molplex provides high margin solutions for established Pharmaceutical companies and the emerging micro-Pharma market in new drug discovery while building its own portfolio of high value therapeutics through shared risk, shared ownership projects. Molplex provides drug optimisation services to Pharmaceutical companies, achieving profitability through high value fee-for-service agreements, while adding shared risk, shared reward projects as commercial success grows
Company Facts
- Operating status: Closed
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Estimated revenue: $1K – $10K
- Total funding: $809.7K
- Last round: Series Unknown (Sep 2012)
- Website: molplex.com
- Phone: 44 1912 111 965
Industries & Categories
Biotechnology, Pharmaceutical
Social Profiles
Canonical: https://fsome.com/organization/molplex-2079815 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.